AT 1001, CAS [[1314801-63-2]]

Produktübersicht

• Artikelname: AT 1001, CAS [[1314801-63-2]]
• Artikelnummer: MCE-HY-135783
• Hersteller Artikelnummer: HY-135783
• Alternativnummer: MCE-HY-135783-25MG,MCE-HY-135783-5MG,MCE-HY-135783-50MG,MCE-HY-135783-100MG,MCE-HY-135783-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

AT 1001 is an orally effective alpha3beta4 nicotinic acetylcholine receptor (alpha3beta4 nAChR) antagonist with a Ki value of 2.64 nM. AT 1001 reversibly blocks Epibatidine (HY-101078)-induced inward currents in HEK cells transfected with alpha3beta4 nAChR. AT 1001 dose-dependently blocks nicotine self-administration behavior in rats, alleviates gluten-induced gastrointestinal symptoms, blocks tight junction toxin-induced immune responses, and reduces the incidence of type 1 diabetes in rats. AT 1001 can be used in the research of nicotine addiction and celiac disease[1][2][3].

Produkteigenschaften

• Molekulargewicht: 309.24
• Reinheit: 99.94
• CAS Nummer: [1314801-63-2]
• Formel: C15H21BrN2
• Target-Kategorie: nAChR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound